IDEAYA Biosciences (IDYA) Cash & Current Investments (2018 - 2026)

IDEAYA Biosciences has disclosed Cash & Current Investments across 9 years of filings, most recently posting $671.2 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $671.2 million, down 3.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $671.2 million (down 3.08% YoY), and the FY2025 annual result was $639.4 million, down 5.46% from the prior year.
• Cash & Current Investments came in at $671.2 million for Q1 2026 at IDEAYA Biosciences, up from $639.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $920.0 million in Q3 2024 to a low of $252.6 million in Q1 2022.
• The 5-year median for Cash & Current Investments is $639.4 million (2025), against an average of $562.1 million.
• Across the five-year window, Cash & Current Investments decreased 16.45% in 2022 and jumped 105.84% in 2024, its largest moves.
• IDEAYA Biosciences' Cash & Current Investments stood at $364.8 million in 2022, then soared by 43.93% to $525.1 million in 2023, then grew by 28.79% to $676.3 million in 2024, then slipped by 5.46% to $639.4 million in 2025, then grew by 4.98% to $671.2 million in 2026.
• The last three Cash & Current Investments figures came in at $671.2 million (Q1 2026), $639.4 million (Q4 2025), and $786.9 million (Q3 2025), per Business Quant data.